Metosartan CH 25 Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg)
Overview Metosartan CH 25 Tablet ER
Extended-release Metosartan CH 25 tablets are a combined medication prescribed for managing hypertension (high blood pressure). This medication lowers blood pressure by promoting vasodilation (widening of blood vessels) and enhancing cardiac efficiency. It also facilitates the excretion of excess fluid and electrolytes. Metosartan CH 25 ER may be ingested with or without food, but consistent daily timing maximizes efficacy. Increased urinary output is a common effect; therefore, daytime administration, or at least four hours prior to sleep, is recommended to minimize nighttime bathroom visits. Dosage and frequency are determined by your physician based on individual needs and treatment goals. Continuous use, as directed, is crucial for sustained therapeutic benefit. Commonly reported side effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular monitoring of kidney function and electrolyte levels is essential. Optimal outcomes are achieved through complementary lifestyle modifications such as balanced nutrition, regular physical activity, and smoking cessation. Adequate hydration is advised to mitigate potential side effects like dry mouth and thirst. Prior to commencing treatment, inform your physician of any existing conditions, including pregnancy, circulatory disorders, liver impairment, or kidney disease, as well as all other medications you are currently using, as potential drug interactions may impact efficacy or alter the medication's effects.
Primary Ingredients of Metosartan CH 25 Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Metosartan CH 25 Tablet ER
Elevated arterial blood pressure
Major Benefits of Metosartan CH 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metosartan CH 25 ER tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While you can take this medication with or without food, consistency in timing is recommended.
Common Side effects of Metosartan CH 25 Tablet ER:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Weakness
- Cold extremities
- Numbness of extremity
- Increased uric acid level in blood
- Increased blood lipid level
- Decreased magnesium level in blood
- Slow heart rate
- Decreased sodium level in blood
- Decreased blood pressure
How to use Metosartan CH 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Metosartan CH 25 ER tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While you can take them with or without food, consistency is key—choose a specific time each day for administration.
How Metosartan CH 25 Tablet ER works:
Telmisartan, metoprolol succinate, and chlorthalidone, combined in Metosartan CH 25 ER tablets, provide effective blood pressure reduction.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metosartan CH 25 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Metosartan CH 25 Extended-Release tablets is contraindicated during pregnancy due to established fetal risk. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Extended-release metoprolol succinate 25 mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the nursing infant.
DrivingUNSAFE
Extended-release metoprolol succinate 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Metosartan CH 25 Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised; indeed, use is generally discouraged in such cases.
LiverCAUTION
Patients with hepatic impairment should use Metosartan CH 25 ER tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Metosartan CH 25 ER tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Metosartan CH 25 Tablet ER :
Should you forget a Metosartan CH 25 Tablet ER dose, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Metosartan CH 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |



